HUTCHMED (LON:HCM) Stock Price Crosses Below 200-Day Moving Average – Should You Sell?

HUTCHMED (China) Limited (LON:HCM)’s stock price passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 258.58 ($3.33) and traded as low as GBX 231 ($2.97). HUTCHMED shares last traded at GBX 233 ($3.00), with a volume of 12,764 shares trading hands.

HUTCHMED Stock Performance

The company has a debt-to-equity ratio of 11.97, a quick ratio of 2.97 and a current ratio of 2.81. The firm has a market capitalization of £2.41 billion, a P/E ratio of -56.77 and a beta of 0.76. The stock has a 50-day moving average of GBX 233.43 and a 200 day moving average of GBX 258.32.

About HUTCHMED

We are among the first global-focused novel drug discovery companies in China. Over the past two decades, we have established a fully integrated R&D platform with world-class discovery and development capabilities. Since inception, we have focused on bringing cancer drug candidates from in-house discovery to patients around the world, with our first three oncology medicines now approved marketed in China, the first of which is also marketed in the U.S.

We have also developed a profitable commercial platform with deep pan-China market access, which manufactures, markets and distributes our novel oncology products, as well as prescription drugs and consumer health products in China.

HUTCHMED is listed on the Nasdaq Global Select Market, the Stock Exchange of Hong Kong Limited and the London Stock Exchange’s AIM market (Nasdaq/AIM:HCM; HKEX:13).